Stratview Research has published a new report titled “Gene Therapy Market” which is segmented by Vector Type (Non-Viral Vectors, Viral Vectors), by Indication Type (Neurological Diseases, Cancer, Hepatological Diseases, Duchenne Muscular Dystrophy, and Others), by Delivery Method Type (In Vivo Gene Therapy, Ex Vivo Gene Therapy), and by Region (North America, Europe, Asia-Pacific, and Rest of the World).

As per the study, the market is expected to grow from US$ 7.66 Billion in 2022 to US$ 23.59 Billion by 2028 at a CAGR of 20.6% during the forecast period of 2022-2028.

Report Highlights

This report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can affect the industry. It provides a thorough analysis of the market segments which include products, applications, and competitor analysis.

The market is bifurcated into various segments. Below given is the segment-wise analysis -

By Indication Type

The Cancer segment is expected to experience the highest growth in the market during the forecast period.

The gene therapy market is segmented into neurological diseases, cancer, Duchenne muscular dystrophy, herpetology, and others.  This growth can be attributed to the approval of a growing number of gene therapies for the treatment of cancer and the rising incidences of hematologic cancers.

By Vector Type

The Non-Viral Vectors segment is expected to grow at a healthy and higher rate over the forecast period, owing to the higher market penetration of oligonucleotide-based non-viral vector gene therapies.

The market is segmented as non-viral and viral vectors. The non-viral vectors’ segment has been further bifurcated into oligonucleotides and others; and the viral vectors’ segment has been further bifurcated into retroviral vectors, adeno-associated virus vectors, and others. 

Which Region is expected to remain the largest market?

North America is estimated to be the largest market during the forecast period with lucrative growth opportunities.

This growth can be attributed to the presence of major players, the rising prevalence of chronic diseases, high and increasing healthcare expenditure, the presence of advanced healthcare infrastructure, and the availability of reimbursements. Europe and Asia-Pacific are also expected to offer substantial growth opportunities during the forecast period.

Who are the Key Players in the Market?

This report provides market intelligence most comprehensively. It also provides critical insights into the key players active in the market, enabling strategic decision-making for the existing market players and those willing to enter the market. The following are the key players active in the Gene Therapy Market:

• Biogen Inc.
• Novartis International AG
• Gilead Sciences, Inc.
• Spark Therapeutics, Inc.
• MolMed S.p.A.
• Orchard Therapeutics plc.
• Sibiono GeneTech Co. Ltd.
• Shanghai Sunway Biotech Co., Ltd.
• Bluebird Bio
• Human Stem Cells Institute PJSC
• AnGes MG, Inc.
• Alnylam Pharmaceuticals, Inc.
• Sarepta Therapeutics, Inc.
• Jazz Pharmaceuticals, Inc.
• Akcea Therapeutics
• Dynavax Technologies Corporation.

Key questions answered by the report.

• What is the projected CAGR for revenue from the Gene Therapy Market during the forecast period?
• What would the market be valued at by 2028?
• What is a major driving factor for the growth of the market?
• Which region accounted for the largest revenue share in the Gene Therapy Market?
• Which are the major market players?

Custom Research:

Stratview Research delivers custom research services across sectors. In case of any custom research requirements, please send your inquiry to [email protected]. Or connect with our experts at +1-313-307-4176.

About Us

Stratview Research is a global market research firm, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients insightful market data to aid strategic decision-making. These exclusive reports are the result of exclusive research methodology and are available for key industries such as chemicals, composites, advanced materials, technology, renewable energy, and more.